Company: STAA
Filing Date: 2025-11-06
Form Type: PX14A6G
Source: 0001193125-25-269485
Chunk: 4

Company: STAAR SURGICAL CO
Filing Date: 2025-11-06
Form: PX14A6G
Chunk 4
---
con’s presentation copies a chart from the report showing certain negative trend data from the Chinese Consumer Confidence Index. But the report fails to relate McKinsey’s own take on the same data, where they observe, “Yet beyond these headlines, consumers appear to have quietly moved on ... Retail sales are climbing in key categories.” McKinsey & Co also found that “foreign brands continue to find fertile ground for scaling in China.” This overall outlook set forth in the report is in contrast to Alcon’s own attempt to paint a dire economic outlook for the China market and to underplay STAAR’s mid-to long-term growth potential. Board Composition We also believe the Board would benefit from additional shareholder perspective and the presence of a director with meaningful economic ownership. As noted previously, I would be pleased to serve on the Board to provide that perspective and would welcome a discussion. It is telling that Alcon’s presentation urges STAAR shareholders to support the proposed merger — purportedly in STAAR shareholders’ best interests — while expressing no support for, and implicitly opposing, my offer to be considered by the Board for membership. Yunqi is one of the Company’s largest shareholders and has a deep understanding of the Chinese market, sustained conviction in STAAR’s products, and full alignment with shareholder interests. It is time to listen to shareholders either way.A reported 72% of outstanding STAAR shares resoundingly voted againstthe transaction as of the originally scheduled special meeting date of October 23. 1We take this figure to be accurate, as neither STAAR nor Alcon has disputed it since the initial report on October 24. Shareholders already knew what they needed to know as of October 23, and the Company’s latest earnings news only reinforces what was already clear to those who voted against the merger. With all of this said, we continue to be available to work constructively with you and management to realize the significant value that STAAR can create. We remain confident in STAAR’s long-term prospects and its ability to deliver strong revenue growth and profitability. Sincerely, Christopher M. Wang Founder and Chief Investment Officer Yunqi Capital Limited

About Yunqi Capital

Yunqi Capital is a Hong Kong headquartered investment manager with over US$250 million in assets under management. The firm deploys a fundamental
long-short equity strategy, with a concentrated portfolio, that is primarily invested in the equity securities of companies with a significant China connection. Yunqi Capital is led by CIO Chris Wang, an experienced portfolio manager with a strong
track record of generating attractive returns